Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2008 Jun;16(6):1355-62.
doi: 10.1038/oby.2008.201. Epub 2008 Apr 10.

Effect of 6-month calorie restriction and exercise on serum and liver lipids and markers of liver function

Collaborators, Affiliations
Randomized Controlled Trial

Effect of 6-month calorie restriction and exercise on serum and liver lipids and markers of liver function

D Enette Larson-Meyer et al. Obesity (Silver Spring). 2008 Jun.

Abstract

Objective: Nonalcoholic fatty liver disease (NAFLD) and its association with insulin resistance are increasingly recognized as major health burdens. The main objectives of this study were to assess the relation between liver lipid content and serum lipids, markers of liver function and inflammation in healthy overweight subjects, and to determine whether caloric restriction (CR) (which improves insulin resistance) reduces liver lipids in association with these same measures.

Methods and procedures: Forty-six white and black overweight men and women (BMI = 24.7-31.3 kg/m(2)) were randomized to "control (CO)" = 100% energy requirements; "CR" = 25%; "caloric restriction and increased structured exercise (CR+EX)"= 12.5% CR + 12.5% increase in energy expenditure through exercise; or "low-calorie diet (LCD)" = 15% weight loss by liquid diet followed by weight-maintenance, for 6 months. Liver lipid content was assessed by magnetic resonance spectroscopy (MRS) and computed tomography (CT). Lipid concentrations, markers of liver function (alanine aminotransferase (ALT), alkaline phosphatase (ALK)), and whole-body inflammation (tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), high-sensitivity C-reactive protein (hsCRP)) were measured in fasting blood.

Results: At baseline, increased liver lipid content (by MRS) correlated (P < 0.05) with elevated fasting triglyceride (r = 0.52), ALT (r = 0.42), and hsCRP (r = 0.33) concentrations after adjusting for sex, race, and alcohol consumption. With CR, liver lipid content was significantly lowered by CR, CR+EX, and LCD (detected by MRS only). The reduction in liver lipid content, however, was not significantly correlated with the reduction in triglycerides (r = 0.26; P = 0.11) or with the changes in ALT, high-density lipoprotein (HDL)-cholesterol, or markers of whole-body inflammation.

Discussion: CR may be beneficial for reducing liver lipid and lowering triglycerides in overweight subjects without known NAFLD.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Relation between intrahepatic lipid (IHL) measured by magnetic resonance spectroscopy (MRS) and the ratio of the attenuation (in Hounsfield units (HU)) of liver tissue relative to spleen tissue (liver-to-spleen ratio) (in HU) measured by computed tomography (CT) (P < 0.05). A lower liver-to-spleen ratio reflects a higher lipid content. Data are shown for the group of white men (open triangles), white women (open circles), black men (black triangles), and black women (black circles).
Figure 2
Figure 2
Liver lipid stores at baseline and after 6 months of treatment with caloric restriction (CR), caloric restriction and increased structured exercise (CR+EX), a low-calorie diet (LCD) or control (see text for treatment details) assessed by (a) magnetic resonance spectroscopy and (b) computed tomography. For (a) intrahepatic lipid (IHL), values at 6 months are significantly different than baseline for all treatment groups (CR, CR+EX, and LCD). *Significantly different from control; significantly different from baseline.

References

    1. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology. 2003;37:1202–1219. - PubMed
    1. Matteoni CA, Younossi ZM, Gramlich T, et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. 1999;116:1413–1419. - PubMed
    1. Tendler DA, UpToDate Pathogenesis of nonalcoholic fatty liver disease. 2006. < www.uptodate.com>.
    1. Browning JD, Szczepaniak LS, Dobbins R, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004;40:1387–1395. - PubMed
    1. Szczepaniak LS, Nurenberg P, Leonard D, et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab. 2005;288:E462–E468. - PubMed

Publication types

MeSH terms